NKT cells are dispensable in the induction of oral tolerance but are indispensable in the abrogation of oral tolerance by prostaglandin E

European Journal of Immunology

Volumn 33, Issue 1, 2003, Pages 183-193

  Ishimitsu, Ryotaro ^a,b   Yajima, Toshiki ^a   Nishimura, Hitoshi ^a   Kawauchi, Hideyuki ^b   Yoshikai, Yasunobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

Author keywords

IL 4; Liver; NKT cell; Oral tolerance; Prostaglandin

Indexed keywords

ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4; MONOCLONAL ANTIBODY; OVALBUMIN; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; KNOCKOUT MOUSE; LIVER CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; TH1 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, SURFACE; DIET; FLOW CYTOMETRY; IMMUNE TOLERANCE; INTERLEUKIN-4; LECTINS, C-TYPE; MICE; OVALBUMIN; PROSTAGLANDINS E; PROTEINS; T-LYMPHOCYTES; TH2 CELLS;

EID: 0037258353     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/immu.200390021     Document Type: Review

References (52)

1. Strobel, S. and Mowat, A. M., Immune responses to dietry antigens: oral tolerance. Immunol. Today 1998. 19: 173-181.
2. Faria, A. M. and Weiner, H. L., Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 1999. 73: 153-264.
3. Miller, A., Lider, O., Roberts, A. B., Sporn, M. B. and Weiner, H. L., Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 1992. 89: 421-425.
4. Chen, Y., Inobe, J., Marks, R., Gonella, P., Kuchroo, V. K. and Weiner, H. L., Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995. 376: 177-180.
5. Chen, Y., Inobe, J., Kuchroo, V. K., Baron, J. L., Janeway, C. A. Jr. and Weiner, H. L., Oral tolerance in myelin basic protein T cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA 1996. 93: 388-391.
6. + cells mediate active suppression. J. Immunol. 1995, 155: 910-916.
7. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. and Weiner, H. L., Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994. 265: 1237-1240.
8. Friedman, A. and Weiner, H. L., Induction of energy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 1994. 91: 6688-6692.
9. Mosmann, T. R. and Coffman, R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989. 7: 145-173.
10. Reiner, S. L. and Seder, R. A., T helper cell differentiation in immune response. Curr. Opin. Immunol. 1995. 7: 360-366.
11. + T cell subsets in vivo. Immunol. Rev. 1991. 123: 189-207.
12. Kweon, M. N., Fujihashi, K., VanCott, J. L., Higuchi, K., Yamamoto, M., McGhee, J. R. and Kiyono, H., Lack of orally induced systemic unresponsiveness in IFN-γ knockout mice. J. Immunol. 1998. 160: 1687-1693.
13. Zhang, Z. Y. and Michael, J. G., Orally inducible immune unresponsiveness is abrogated by IFN-γ treatment. J. Immunol. 1990. 144: 4163-4165.
14. Garside, P., Steel, M., Worthey, E. A., Satoskar, A., Alexander, J., Bluethmann, H., Liew, F. Y. and Mowat, A. M., Th2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 1995. 154: 5649-5655.
15. + T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997. 389: 737-742.
16. Budd, R. C., Miescher, G. C., Lees, R. C., Bron, C. and MacDonald, H. R., Developmentally regulated expression of T cell receptor beta chain in immune thymocytes. J. Exp. Med. 1987. 166: 577-582.
17. + thymocytes selected by MHC class II molecules. Science 1994. 263: 1774-1778.
18. + cells in the liver of mice. J. Exp. Med. 1994. 180: 699-704.
19. + T cells producing IL-4 may be involved in the increased susceptibility of mice with the beige mutation during Salmonella infection. J. Immunol. 1997. 158: 2268-2278.
20. + T cell antigen receptor alpha chain in mice. Proc. Natl. Acad. Sci. USA 1991. 88: 7518-7522.
21. Bendelac, A., Rivera, M. N., Park, J. H. and Roark, S. H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 1997. 15: 535-562.
22. Kawano, T., Cui, J., Koezuka, Y., Tours, I., Kaneko,Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M., CD1d-restricted and TCR-mediated activation of V alpha14 NKTcells by glycosylceramides. Science 1997. 278: 1626-1629.
23. + T lymphocytes. Science 1995. 268: 863-865.
24. Gapin, L., Matsuda, J. L., Surh, S. D. and Kronenberg, M., NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2001. 2: 971-978.
25. + T cell development and early T cell development and early IL-4 production in CD1-deficient mice. Immunity 1997. 6: 459-477.
26. Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S. and Kaer, L. V., CD1d mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997. 6: 469-477.
27. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nagasawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M., Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997. 278: 1623-1626.
28. Porcelli, S. A., Cutting glycolipids down to size. Nat. Immunol. 2001. 3: 191-192.
29. Prigozy, T. I., Naidenko, O., Qasba, P., Elewaut, D., Brossay, L., Khurana, A., Natori, T., Koezuka, Y., Kulkarni, A. and Kronenberg, M., Glycolipid antigen processing for presentation by CD1d molecules. Science 2001. 291: 664-667.
30. Sonoda, K., Exley, H. M., Snapper, S., Balk, S. P. and Stein-Streilein, J., CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 1999. 190: 1215-1226.
31. Yoshikai, Y., Roles of prostagrandins and leukotriens in acute inflammation caused by bacterial infection. Curr. Opin. Infect. Dis. 2001. 14: 257-263.
32. Strassmann, G., Patil-Koota, V., Finkelman, F., Fong, M. and Kambayashi, T., Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 1994. 180: 2365-2370.
33. Takano, M., Nishimura, H., Kimura, Y., Washizu, J., Mokuno, Y., Nimura, Y. and Yoshikai, Y., Prostaglandin E2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice. J. Immunol. 1998. 161: 3019-3025.
34. Mokuno, Y., Takano, M., Matsuguchi, T., Nishimura, H., Washizu, J., Naiki, Y., Nimura, Y. and Yoshikai, Y., Prostaglandin E[1] protects against liver injury induced by Escherichia coli infection via a dominant Th2-like response of liver T cells in mice. Hepatology 1999. 30: 1464-1472.
35. Van der Pouw Kraan, T. C., Boeije, L. C., Smeenk, R. J., Wijdenes, J. and Aarden, L. A., Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 1995. 181: 775-779.
36. 2 among mouse: A possible mechanism to polarize Th2 type response in BALB/c mice. J. Immunol. 2000. 164: 2386-2395.
37. Wu, C-Y., Kening, W., McDyer, J. F. and Robert, A. S., Prostaglandin E2 and dexamethazone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 1998. 161: 2723-2730.
38. Smiley, S. T., Kaplan, M. H. and Grusby, M. J., Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 1997. 275: 977-979.
39. Khoury, S. J., Hancock, W. W. and Weiner, H. L., Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 1992. 176: 1355-1364.
40. Neurath, M. F., Fuss, I., Kelsall, B. L., Presky, D. H., Waegell, W. and Strober, W., Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 1996. 183: 2605-2616.
41. Liu, Y. and Janeway, C. A. Jr., Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J. Exp. Med. 1990. 172: 1735-1739.
42. Lee, H. O., Miller, S. D., Hurst, S. D., Tan, L. J., Cooper, C. J. and Barett, T. A., Interferon gamma induction during oral tolerance reduces T cell migration to sites of inflammation. Gastroenterology 2000. 119: 129-138.
43. Mowat, A. M., Steel, M., Leishman, A. J. and Garside, P., Normal induction of oral tolerance in the absence of a functional IL-12-dependent IFN-gamma signaling pathway. J. Immunol. 1999. 163: 4728-4736.
44. 4 prostaglandin receptors in mouse macrophage-like cell line, J 774.1. Biochem. Biophys. Res. Commun. 1998. 251: 727-731.
45. Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S. and Narumiya, S., Altered pain perception and inflammatory response in mice lacking prostacycline receptor. Nature 1997. 3: 678-682.
46. 2 subtype. J. Biol. Chem. 1993. 268: 7759-7762.
47. Neumann, M., Grieshammer, T., Chuvpilo, S., Kneitz, B., Lohoff, M., Schimpl, A., Franza, B. R. and Serfling, E., ReIA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 1995. 14: 1991-2004.
48. Platze, C., Meisel, C., Vogt, K., Platzer, M. and Volk, H. D., Upregulation of monocytic IL-10 by tumor necrosis factor-a and cAMP elevating drugs. Int. Immunol. 1995. 7: 517-523.
49. Miyamoto, K., Miyake, S. and Yamamura, T., A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001. 413: 531-534.
50. Kurland, J. I. and Bockman, R., Prostageandin E production by human blood monocytes and mouse peritoneal macrophages. J. Exp. Med. 1978. 147: 952-957.
51. Phipps, R. P., Stein, S. H. and Roper, R. L., A new view of prostageandin E regulation of immune response. Immunol. Today 1991. 12: 349-352.
52. Newberry, R. D., Stenson, W. F. and Lorenz, R.G., Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat. Med. 1999. 5: 900-906.